论文部分内容阅读
希舒美是一种新的口服大环内酯类抗生素,具有高度酸稳定性,口服后在胃中破坏很少,从十二指肠吸收后入血,很快穿透到全身组织中,血清水平迅速降低,而在组织细胞中对溶酶体有高度亲和力,可维持药物在感染组织中的水平。由于它具有长的半衰期,因此可以保证在停药后在组织中的药物浓度可维持数天。本科87年4月至6月对30例急性耳鼻咽喉感染病例进行临床试验,取得良好效果。见报道:
Xishomei is a new oral macrolide antibiotics, with a high degree of acid stability, little damage in the stomach after oral absorption from the duodenum into the blood, and soon penetrate into the body tissue, Serum levels are rapidly reduced, whereas lysosomes are highly affinitive in tissue cells to maintain drug levels in the infected tissue. Because of its long half-life, it is guaranteed that the drug concentration in the tissue will persist for several days after discontinuation. Undergraduate 87 April to June 30 cases of acute otolaryngological infections in clinical trials, and achieved good results. See report: